XTL Biopharmaceuticals Ltd (XTLB)
2.53
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
2.53
0.00 (0.00%)
After-Hours: 20:00
XTL Biopharmaceuticals Cash from Operations (TTM)
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2014 | -2.47M |
September 30, 2014 | -2.316M |
June 30, 2014 | -2.619M |
March 31, 2014 | -2.743M |
December 31, 2013 | -2.499M |
September 30, 2013 | -2.387M |
June 30, 2013 | -2.10M |
March 31, 2013 | -1.776M |
December 31, 2012 | -1.506M |
September 30, 2012 | -0.87M |
June 30, 2012 | -0.645M |
Date | Value |
---|---|
March 31, 2012 | -1.186M |
December 31, 2011 | -1.312M |
September 30, 2011 | |
June 30, 2011 | |
March 31, 2011 | |
December 31, 2010 | |
September 30, 2010 | -0.681M |
June 30, 2010 | -0.707M |
March 31, 2010 | -0.712M |
December 31, 2009 | -2.488M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
Compugen Ltd | -- |
Pluri Inc | -18.47M |
BioLine Rx Ltd | -22.61M |
Can Fite Biofarma Ltd | -- |
BiomX Inc | -21.29M |